Core as a novel viral target for hepatitis C drugs

Viruses

Volumn 2, Issue 8, 2010, Pages 1734-1751

  Strosberg, Arthur Donny ^a   Kota, Smitha ^a   Takahashi, Virginia ^a   Snyder, John K ^b   Mousseau, Guillaume ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Boston University   (United States)

Author keywords

Core dimerization; HCV; Hepatitis C virus; Peptide inhibitors; Small molecule inhibitors; Virus assembly

Indexed keywords

ANTI HEPATITIS C VIRUS AGENT; ANTIVIRUS AGENT; CAPSID PROTEIN; GLYCOPROTEIN E1; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5A; PEGINTERFERON; PEPTIDE DERIVATIVE; RIBAVIRIN; SL 173; SL 174; SL 175; SL 201; SL 209; UNCLASSIFIED DRUG;

DIMERIZATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; DRUG TOLERABILITY; HEPATITIS C; HOST RESISTANCE; HUMAN; IC 50; NONHUMAN; OLIGOMERIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; VIRION; VIRUS ASSEMBLY; VIRUS CORE; VIRUS NUCLEOCAPSID; VIRUS PARTICLE;

HEPATITIS C VIRUS; MIRIDAE;

EID: 78651227688     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v2081734     Document Type: Review

References (82)

1. Alter, M.J. Epidemiology of Hepatitis C infection World J. Gastroenterol. 2007, 13, 2436-2441.
2. Lavanchy, D. The global burden of hepatitis C. Liver Int. 2009, 29, 74-81.
3. Robertson, B.; Myers, G.; Howard, C.; Brettin, T.; Bukh, J.; Gaschen, B.; Gojobori, T.; Maertens, G.; Mizokami, M.; Nainan, O.; Netesov, S.; Nishioka, K.; Shini, T.; Simmonds, P.; Smith, D.; Stuyver, L.; Weiner, A. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch. Virol. 1998, 143, 2493-2503.
4. Simmonds, P.; Holmes, E.C.; Cha, T.A.; Chan, S.W.; McOmish, F.; Irvine, B.; Beall, E.; Yap, P.L.; Kolberg, J.; Urdea, M.S. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 1993, 74, 2391-2399.
5. Lindenbach, B.D.; Thiel, H.J.; Rice, C.M. Flaviviridae: The viruses and their replication. In Fields Virology, 45th ed.; Knipe, D.M., Howley, P.M., Eds.; Lippincott-Raven Publishers, Philadelphia, PA, USA, 2007; 1, pp. 1101-1152.
6. Giannini, C.; Brechot, C. Hepatitis C virus biology. Cell Death Differ. 2003, 10, S27-S38.
7. Choo, Q.; Kuo, G.; Weiner, A.; Overby, L.; Bradley, D.; Houghton, M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244, 359-365
8. Dubuisson, J. Hepatitis C virus proteins. World J. Gastroenterol. 2007, 13, 2406-2415.
9. Lindenbach, B.D.; Rice, C.M. Unravelling hepatitis C virus replication from genome to function. Nature 2005, 436, 933-938.
10. Cristina, J.; Moreno-del Pilar, M.; Moratorio, G. Hepatitis C virus genetic variability in patients undergoing antiviral therapy. Virus Res. 2007, 127,185-194.
11. Meurs, E.F.; Breiman, A. The interferon inducing pathways and the hepatitis C virus. World J. Gastroenterol. 2007, 13, 2446-2454.
12. Wang, P.; Chun, B.K.; Rachakonda, S.; Du, J.; Khan, N.; Shi, J.; Stec, W.; Cleary, D.; Ross, B.S.; Sofia, M.J. An efficient and diastereoselective synthesis of PSI-6130: a clinically efficacious inhibitor of HCV NS5B polymerase. J. Org. Chem. 2009, 74, 6819-6824.
13. Lalezari, J.; Asmuth, D.; Vargas, H.; DubucPatrick, G.; Liu, W.; Pietropaolo, K.; Zhou, X.J.; Suulivan-Bolyal, J.; Mayers, D. The IDX -08C-003 investigator group, Antiviral Activity, Pharmacokinetics and Safety of IDX184 in Combination with Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Treatment-Naive HCV Genotype 1-infected Subjects. EasL 2010, 4.15.10.
14. Ruebsam, F.; Tran, C.V.; Li, L.S.; Kim, S.H.; Xiang, A.X.; Zhou, Y.; Blazel, J.K.; Sun, Z.; Dragovich, P.S.; Zhao, J.; McGuire, H.; Murphy, D.E.; Tran, M.T.; Stankovic, N.; Ellis, D.A.; Gobbi, A.; Showalter, R.E.; Webber, S.E.; Shah, A.M.; Tsan, M.; Patel, R.A.; LeBrun, L.A.; Hou, H.J.; Kamran, R.; Sergeeva, M.V.; Bartkowski, D.M.; Nolan, T.G.; Norris, D.A.; Kirkovsky, L. 5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase. Bioorg. Med. Chem. Lett. 2009, 19, 451-458.
15. Gentile, I.; Carleo, M.A.; Borgia, F.; Castaldo, G.; Borgia, G. The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus. Expert Opin. Investig. Drugs 2010, 19, 151-159.
16. Prevelige Jr., P.E. Inhibiting Virus Capsid Assembly by Altering the Polymerization Pathway. Trends Biotechnol. 1998, 16, 61-65.
17. Bourne, C.R.; Finn, M.G.; Zlotnick, A. Global Structural Changes in Hepatitis B Virus Capsids Induced by the Assembly Effector HAP1. J. Virol. 2006, 80, 11055-11061.
18. Chan, D.C.; Fass, D.; Berger, J.M.; Kim, P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997, 89, 263-273.
19. Sticht, J.; Humbert, M.; Findlow, S.; Bodem, J.; Müller, B.; Dietrich, U.; Werner, J.; Kräusslich, H.G. A peptide inhibitor of HIV-1 assembly in-vitro. Nat. Struct. Mol. Biol. 2005, 12, 671-677.
20. Akuta, N.; Suzuki, F.; Hirakawa, M.; Kawamura, Y.; Yatsuji, H.; Sezaki, H.; Suzuki, Y.; Hosaka, T.; Kobayashi, M.; Saitoh, S.; Arase, Y.; Ikeda, K.; Chayama, K.; Nakamura, Y.; Kumada, H. Amino acid substitution in HCV core region and gentic variation near IL28B gene predict viral reposne to telaprevir with peginterferon and ribavirin. Hepatology 2010, Preprint mar 2010.
21. Courcambeck, J.; Bouzidi, M.; Perbost, R.; Jouirou, B.; Amrani, N.; Cacoub, P.; Pepe, G.; Sabatier, J.M.; Halfon, P. Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations. Antivir. Ther. 2006, 11, 847-855.
22. De Francesco, R.; Carfi, A. Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Adv. Drug Delivery. Rev. 2007, 59, 1242-1262.
23. Kota, S.; Coito, C.; Mousseau, G.; Lavergne, J-P; Strosberg, A.D. Peptide inhibitors of Hepatitis C Virus core oligomerization and virus production. J. Gen. Virol. 2009, 90,1319-1328.
24. Lo, S.Y.; Selby, M.J.; Ou, J.H. Interaction between hepatitis C virus core protein and E1 envelope protein. J. Virol. 1996, 70, 5177-5182.
25. Murray, C.L.; Jones, C.T.; Tassello, J.; Rice, C.M. Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Infectious Virus Production. J. Virol. 2007, 81, 10220-10231.
26. Ma, Y.; Yates, J.; Liang, Y.; Lemon, S.M.; Yi, M. NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J. Virol. 2008, 82, 7624-7639.
27. McLauchlan, J. Lipid droplets and hepatitis C infection. Biochim. Biophys. Acta 2009, 1791, 552-559.
28. Miyanari, Y.; Atsuzawa, K.; Usuda, N.; Watashi, K.; Hishiki, T.; Zayas, M.; Bartenschlager, R.; Wakita, T.; Hijikata, M.; Shimotohno, K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 2007, 9, 1089-1097
29. Flajolet, M.; Rotondo, G.; Daviet, L.; Bergametti, F.; Inchauspe, G.; Tiollais, P.; Transy, C.; Legrain, P. A genomic approach of the hepatitis C virus generates a protein interaction map. Gene 2000, 242, 369-379.
30. Goh, P.Y.; Tan, Y.J.; Lim, S.P.; Lim, S.G.; Tan, Y.H.; Hong, W.J. The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. Virology 2001, 290, 224-236.
31. Dimitrova, M.; Imbert, I.; Kieny, M.P.; Schuster, C. Protein-protein interactions between hepatitis C virus nonstructural proteins. J. Virol. 2003, 77, 5401-5414.
32. Masaki, T.; Suzuki, R.; Murakami, K.; Aizaki, H.; Ishii, K.; Murayama, A.; Date, T.; Matsuura, Y.; Miyamura, T.; Wakita, T.; Suzuki, T. Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles J. Virol. 2008, 82, 7964-7976.
33. Appel, N.; Zayas, M.; Miller, S.; Krijnse-Locker, J.; Schaller, T.; Friebe, P.; Kallis, S.; Engel, U.; Bartenschlager, R. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 2008, 4, e1000035.
34. Duvignaud, J.B.; Savard, C.; Fromentin, R.; Majeau, N.; Leclerc, D.; Gagné, S.M. Structure and dynamics of the N-terminal half of hepatitis C virus core protein: An intrinsically unstructured protein. Biochem. Biophys. Res. Commun. 2008, 378, 27-31.
35. Barba, G.; Harper, F.; Harada, T.; Kohara, M.; Goulinet, S.; Matsuura, Y.; Eder, G.; Schaff, Z.; Chapman, M.J.; Miyamura, T.; Brechot, C. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 1200-1205.
36. Shavinskay, A.; Boulant, S.; Penin, F.; McLauchlan, J.; Bartenschlager, R. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J.Biol.Chem. 2007, 282, 37158-37169.
37. Penin, F.; Dubuisson, J.; Rey, F.A.; Moradpour, D.; Pawlotsky, J.M. Structural biology of hepatitis C virus. Hepatology 2004, 39, 5-19.
38. Santolini, E.; Migliaccio, G.; LaMonica, N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 1994, 68, 3631-3641.
39. Hüssy, P.; Langen, H.; Mous, J.; Jacobsen, H. Hepatitis C Virus Core Protein: Carboxy-Terminal Boundaries of Two Processed Species Suggest Cleavage by a Signal Peptide Peptidase Virology 1996, 224, 93-104.
40. McLauchlan, J.; Lemberg, M.K.; Hope, G.; Martoglio, B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 2002, 21, 3980-3988.
41. Ai, L.; Lee, Y.W.; Chen, S.S. Characterization of hepatitis C virus core protein multimerization and membrane envelopment: revelation of a cascade of core-membrane interactions. J. Virol. 2009, 83, 9923-9939.
42. Jones, C.T.; Murray, C.; Eastman, D.K.; Tassello, J.; Rice, C.M. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J. Virol. 2007, 81, 8374-8383.
43. Yi, M.; Ma, Y.; Yates, J.; Lemon, S.M. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J. Virol. 2007, 81, 629-638.
44. Popescu, C.I.; Dubuisson, J. Role of lipid metabolism in hepatitis C virus assembly and entry. Biol. Cell 2009, 102, 63-74.
45. Targett-Adams, P.; Boulant, S.; Douglas, M.W.; McLauchlan, J. Lipid Metabolism and HCV Infection. Viruses 2010, 2,1195-1217.
46. Kopp, M.; Murray, C.L.; Jones, C.T.; Rice, C.M. Genetic analysis of the carboxy -terminal region of the Hepatitis C virus core protein. J. Virol. 2010, 84, 1666-1673.
47. McLauchlan, J. Hepatitis C virus: viral proteins on the move. Biochem. Soc. Trans. 2009, 37, 986-990.
48. Andre, P.; Komurian-Pradel, F.; Deforges, S.; Perret, M.; Berland, J.L.; Sodoyer, M.; Pol, S.; Brechot, C.; Paranhos-Baccala, G.; Lotteau, V. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 2002, 76, 6919-6928.
49. Depla, M.; Uzbekov, R.; Hourioux, C.; Blanchard, E.; LeGouge, A.; Gillet, L.; Roingeard, P. Ultrastructural and quantitative analysis of the lipid droplet clustering induced by hepatitis C virus core protein. Cell Mol. Life Sci. 2010, DOI:0.1007/s00018-010-0373-z.
50. Kim, M.; Ha, Y.; Park, H.J. Structural requirements for assembly and homotypic interactions of the hepatitis C virus core protein. Virus Res. 2006, 122,137-143.
51. Boulant, S.; Targett-Adams, P.; McLauchlan, J. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J. Gen. Virol. 2007, 88, 2204-2213.
52. Cristofari, G.; Ivanyi-Nagy, R.; Gabus, C.; Boulant, S.; Lavergne, J.P.; Penin, F.; Darlix, J.L. The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro. Nucleic Acids Res. 2004, 32, 2623-2631.
53. Ivanyi-Nagy, R.; Kanevsky, I.; Gabus, C.; Lavergne, J.P.; Ficheux, D.; Penin, F.; Fosse, P.; Darlix, J.L. Analysis of hepatitis C virus RNA dimerization and core-RNA interactions. Nucleic Acids Res. 2006, 34, 2618-2633.
54. Boulant, S.; Montserret, R.; Hope, R.G.; Ratinier, M.; Targett-Adams, P.; Lavergne, J.P.; Penin, F.; McLauchlan, J. Structural determinants that target the hepatitis C virus core protein to lipid droplets. J. Biol. Chem. 2006, 281, 22236-22247.
55. Boulant, S.; Vanabelle, C.; Ebel, C.; Penin, F.; Lavergne, J.P. Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features. J. Virol. 2005, 79, 11353-11365.
56. Lemberg, M.K.; Martoglio, B. Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. Mol. Cell. 2002, 10, 735-744.
57. Okamoto, K.; Mori, Y.; Komoda, Y.; Okamoto, T.; Okochi, M.; Takeda, M.; Suzuki, T.; Morishi, K.; Matsuura, Y. Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation. J. Virol. 2008, 82, 8349-8361.
58. Yasui, K.; Wakita, T.; Tsukiyama-Kohara, K.; Funahashi, S.-I.; Ichikawa, M.; Kajita, T.; Moradpour, D.; Wands, J.R.; Kohara, M. The Native Form and Maturation Process of Hepatitis C Virus Core Protein. J. Virol. 1998, 72, 6048-6055.
59. Kunkel, M.; Lorinczi, M.; Rijnbrand, R.; Lemon, S.M.; Watowich, S.J. Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J. Virol. 2001, 75, 2119-2129.
60. Boulant, S.; Targett-Adams, P.; McLauchlan, J. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J. Gen. Virol. 2007, 88, 2204-2213.
61. Fromentin, R.; Majeau, N.; Laliberte Gagne, M.E.; Boivin, A.; Duvignaud, J.B.; Leclerc, D. A method for in vitro assembly of hepatitis C virus core protein and for screening of inhibitors. Anal. Biochem. 2007, 366, 37-45.
62. Matsumoto, M.; Hsieh, T.Y.; Zhu, N.; VanArsdale, T.; Hwang, S.B.; Jeng, K.S.; Gorbalenya, A.E.; Lo, S.Y.; Ou, J.H.; Ware, C.F.; Lai, M.M. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J. Virol. 1997, 71, 1301-1309.
63. Nolandt, O.; Kern, V.; Muller, H.; Pfaff, E.; Theilmann, L.; Welke, R.; Krausslich, H.G. Analysis of hepatitis C virus core protein interaction domains. J. Gen. Virol. 1997, 78, 1331-1340.
64. Klein, K.C.; Polyak, S.J.; Lingappa, J.R. Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J. Virol. 2004, 78, 9257-9269.
65. Majeau, N.; Gagne, V.; Boivin, A.; Bolduc, M.; Majeau, J.A.; Ouellet, D.; Leclerc, D. The Nterminal half of the core protein of hepatitis C virus is sufficient for nucleocapsid formation. J. Gen. Virol. 2004, 85, 971-981.
66. Majeau, N.; Fromentin, R.; Savard, C.; Duval, M.; Tremblay, M.J.; Leclerc, D. Palmitoylation of hepatitis C virus core protein is important for virion production. J. Biol. Chem. 2009, 85, 971-981.
67. Moriya, K.; Fujie, H. The Core Protein of Hepatitis C Virus Induces Hepatocellular Carcinoma in Transgenic Mice. Nat. Med. 1998, 4, 1065-1069.
68. Moriya, K.; Yotsuyanagi, H.; Shintani, Y.; Fujie, H.; Ishibashi, K.; Matsuura, Y.; Miyamura, T.; Koike, K. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 1997, 78, 1527-1531.
69. Kota, S.; Scampavia, L.; Spicer, T.; Beeler, A.B.; Takahashi, V.; Snyder, J.K.; Porco, J.A. Jr.; Hodder, P.; Strosberg, A.D. A homogeneous time resolved fluorescence assay for identifying inhibitors of Hepatitis C virus dimerization. Assay Drug Dev. Technol. 2010, 8, 96-105.
70. Wei, W.; Cai, C.; Kota, S.; Takahashi, V.; Strosberg, A.D.; Snyder, J.K. New Small Molecule Inhibitors of Hepatitis C Virus Bioorg. Med. Chem. Lett. 2009, 19, 6926-6930.
71. Peppard, J.; Glickman, F.; He, Y.; Hu, S.I.; Doughty, J.; Goldberg, R. Development of a highthroughput screening assay for inhibitors of aggrecan cleavage using luminescent oxygen channeling (AlphaScreen). J. Biomol. Screen. 2003, 8, 149-156.
72. Wells, J.A.; McClendon, C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450, 1001-1009.
73. Nolandt, O.; Kern, V.; Muller, H.; Pfaff, E.; Theilmann, L.; Welker, R.; Krausslich, H.G. Analysis of hepatitis C virus core protein interaction domains. J. Gen. Virol. 1997, 78, 1331-1340.
74. Mousseau, G.; Strosberg, A.D. The Scripps Research Institute, Jupiter, FL, USA. Personal communication, 2008.
75. Cordell, G.A. The Aspidosperma Alkaloids. In The Alkaloids, Manske, R.H.F., Rodrigo, R.G.A., Eds.; Academic Press, NewYork, NY, USA, 1978, 17, pp. 199-384.
76. Saxton, J.E. Alkaloids of the Aspidospermine Group. In The Alkaloids. Cordell, G.A, Ed.; Academic Press: New York, NY, USA, 1998, 51, pp. 2-198.
77. Benson, S.C.; Lee, L.; Yang, L.; Snyder, J.K. Intramolecular Inverse Electron Demand Diels-Alder Reactions of Tryptamine with Tethered Heteroaromatic Azadienes. Tetrahedron 2000, 56, 1165-1180.
78. Lindenbach, B.D.; Evans, M.J.; Syder, A.J.; Wolk, B.; Tellinghuisen, T.L.; Liu, C.C.; Maruyama, T.; Hynes, R.O.; Burton, D.R.; McKeating, J.A.; Rice, C.M. Complete replication of hepatitis C virus in cell culture. Science 2005, 309, 623-626.
79. Zhong, J.; Gastaminza, P.; Cheng, G.; Kapadia, S.; Kato, T.; Burton, D.R.; Wieland, S.F.; Uprichard, S.L.; Wakita, T.; Chisari, F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 9294-9299.
80. Wakita, T.; Pietschmann, T.; Kato, T.; Date, T.; Miyamoto, M.; Zhao, Z.; Murthy, K.; Habermann, A.; Krausslich, H.G.; Mizokami, M.; Bartenschlager, R.; Liang, T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11, 791-796.
81. Cheng, G.; Montero, A.; Gastaminza, P.; Whitten-Bauer, C.; Wieland, S.F.; Isogawa, M.; Fredericksen, B.; Selvarajah, S.; Gallay, P.A.; Ghadiri, M.R.; Chisari, F.V. A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 3088-3093.
82. Heller, T.; Saito, S.; Auerbach, J.; Williams, T.; Moreen, T.R.; Jazwinski, A.; Cruz, B.; Jeurkar, N.; Sapp, R.; Luo, G.; Liang, T.J. An in vitro model of hepatitis C virion production. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 2579-2583.